HK1207963A1 - Oral pharmaceutical formulation of bcs class iii molecules bsc iii - Google Patents

Oral pharmaceutical formulation of bcs class iii molecules bsc iii

Info

Publication number
HK1207963A1
HK1207963A1 HK15108555.3A HK15108555A HK1207963A1 HK 1207963 A1 HK1207963 A1 HK 1207963A1 HK 15108555 A HK15108555 A HK 15108555A HK 1207963 A1 HK1207963 A1 HK 1207963A1
Authority
HK
Hong Kong
Prior art keywords
iii
bsc
pharmaceutical formulation
oral pharmaceutical
molecules
Prior art date
Application number
HK15108555.3A
Other languages
English (en)
Chinese (zh)
Inventor
Caroline Ailhas
Catherine Herry
Original Assignee
Ethypharm Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethypharm Sa filed Critical Ethypharm Sa
Publication of HK1207963A1 publication Critical patent/HK1207963A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
HK15108555.3A 2012-06-14 2015-09-01 Oral pharmaceutical formulation of bcs class iii molecules bsc iii HK1207963A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1255593A FR2991879B1 (fr) 2012-06-14 2012-06-14 Formulation pharmaceutique orale de molecules bcs de classe iii
PCT/EP2013/062398 WO2013186370A1 (fr) 2012-06-14 2013-06-14 Formulation pharmaceutique orale de molecules bcs de classe iii

Publications (1)

Publication Number Publication Date
HK1207963A1 true HK1207963A1 (en) 2016-02-19

Family

ID=48626457

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15108555.3A HK1207963A1 (en) 2012-06-14 2015-09-01 Oral pharmaceutical formulation of bcs class iii molecules bsc iii

Country Status (6)

Country Link
US (1) US10258692B2 (de)
EP (1) EP2861216B1 (de)
ES (1) ES2733222T3 (de)
FR (1) FR2991879B1 (de)
HK (1) HK1207963A1 (de)
WO (1) WO2013186370A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190282500A1 (en) 2016-09-09 2019-09-19 Cutispharma, Inc. Suspensions and diluents for metronidazole and baclofen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100784752B1 (ko) * 2000-02-04 2007-12-13 다케다 야쿠힌 고교 가부시키가이샤 안정한 에멀젼 조성물
US20050090554A1 (en) * 2003-09-12 2005-04-28 John Devane Treatment of gastroparesis and nonulcer dyspepsia with GABAB agonists
CA2537029C (en) * 2003-11-26 2013-03-12 Likan Liang Micellar systems useful for delivery of lipophilic or hydrophobic compounds
EP1961412A1 (de) * 2006-12-27 2008-08-27 LEK Pharmaceuticals D.D. Selbstmikroemulgierende Arzneimittelabgabesysteme
US20100029771A1 (en) * 2008-07-31 2010-02-04 Olivier Ameisen Treatment of addictive disorders

Also Published As

Publication number Publication date
WO2013186370A1 (fr) 2013-12-19
US10258692B2 (en) 2019-04-16
EP2861216A1 (de) 2015-04-22
EP2861216B1 (de) 2019-04-17
FR2991879A1 (fr) 2013-12-20
ES2733222T3 (es) 2019-11-28
FR2991879B1 (fr) 2014-11-21
US20150165032A1 (en) 2015-06-18

Similar Documents

Publication Publication Date Title
HK1255336A1 (zh) 藥物製劑及其製備方法
ZA201703992B (en) Inhalable pharmaceutical compositions
IL252566B (en) Pharmacy preparations and methods
IL233756A (en) History of hydroxamic acid and their pharmaceutical preparations
IL236024A (en) The history of benzimidazole-proline and its pharmaceutical preparations
HK1203812A1 (en) Novel pharmaceutical formulations
EP3038465A4 (de) Oral anzuwendende arzneiformulierung mit omarigliptin
HK1203815A1 (en) Pharmaceutical compositions and methods for their preparation
HK1199821A1 (en) Oral pharmaceutical composition
HK1199822A1 (zh) 口服給藥用醫藥組合物
HK1205146A1 (en) Pharmaceutical formulation
IL237139A0 (en) Pharmaceutical compositions of memantine
HK1205683A1 (en) Pharmaceutical formulation having improved stability
IL238059A0 (en) History of pyrrolidine, and pharmaceutical preparations containing them
EP2874987A4 (de) Alpha- und gamma-truxillinsäurederivate und pharmazeutische zusammensetzungen daraus
HK1207963A1 (en) Oral pharmaceutical formulation of bcs class iii molecules bsc iii
GB201208315D0 (en) Pharmaceutical methods and compositions
EP2884963A4 (de) Stabile pharmazeutische formulierung von cabazitaxel
GB201207064D0 (en) Pharmaceutical compositions comprising 15-hetre and methods of using the same
GB201211403D0 (en) Pharmaceutical formulations